David G. Mata

A Nicotinic Acetylcholine Receptor Agonist Prevents Loss of Retinal Ganglion Cells in a Glaucoma Model

Kazuhiro Iwamoto, Patrick J. Birkholz, Austin Schipper et al. · Investigative Ophthalmology & Visual Science · 2014 · 44 citations · Full text

Retinal ganglion cell neuroprotection induced by activation of alpha7 nicotinic acetylcholine receptors

David G. Mata, David M. Linn, Cindy L. Linn · Neuropharmacology · 2015 · 31 citations

Ganglion Cell, Retina, Ophthalmology +10

Investigation of Evolved Paraoxonase-1 Variants for Prevention of Organophosphorous Pesticide Compound Intoxication

David G. Mata, Peter Rezk, Praveena Sabnekar et al. · Journal of Pharmacology and Experimental Therapeutics · 2014 · 21 citations

Assessing the stoichiometric efficacy of mammalian expressed paraoxonase-1 variant I-F11 to afford protection against G-type nerve agents

David G. Mata, Praveena Sabnekar, Cetara A. Watson et al. · Chemico-Biological Interactions · 2016 · 11 citations

Molecular Pharmacology, Medicine, Stoichiometric Efficacy +10

Insights into the Mechanism of Paraoxonase-1: Comparing the Reactivity of the Six-Bladed β-Propeller Hydrolases

Timothy J. Grunkemeyer, David G. Mata, Kiran Kumar Doddapaneni et al. · Biochemistry · 2018 · 10 citations